Bausch & Lomb Corp (BLCO.TO)
21.06
-0.04
(-0.19%)
CAD |
TSX |
May 31, 16:00
Bausch & Lomb Revenue (Quarterly): 1.482B for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.482B |
| December 31, 2023 | 1.597B |
| September 30, 2023 | 1.351B |
| June 30, 2023 | 1.391B |
| March 31, 2023 | 1.260B |
| December 31, 2022 | 1.347B |
| September 30, 2022 | 1.229B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.200B |
| March 31, 2022 | 1.126B |
| December 31, 2021 | 1.261B |
| September 30, 2021 | 1.195B |
| June 30, 2021 | 1.147B |
| March 31, 2021 | 1.115B |
| December 31, 2020 | 1.230B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.115B
Minimum
Mar 2021
1.597B
Maximum
Dec 2023
1.281B
Average
1.245B
Median
Revenue (Quarterly) Benchmarks
| Bausch Health Companies Inc | 2.902B |
| Biocure Technology Inc | -- |
| Core One Labs Inc | 0.0937M |
| Nova Mentis Life Science Corp | 0.0283M |
| Nanosphere Health Sciences Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -225.12M |
| Total Expenses (Quarterly) | 1.461B |
| EPS Diluted (Quarterly) | -0.6471 |
| Enterprise Value | 13.28B |
| Gross Profit Margin (Quarterly) | 61.42% |
| Profit Margin (Quarterly) | -15.20% |
| Earnings Yield | -6.15% |
| Operating Earnings Yield | 3.87% |
| Normalized Earnings Yield | -4.920 |